Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy

Clinical trial NCT02116530 · COMPLETED

Trial details

NCT number: NCT02116530
Sponsor: Alliance for Clinical Trials in Oncology
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hematopoietic/Lymphoid Cancer Nausea and Vomiting Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2014-08-20
Primary completion: 2015-04-04
Enrollment: 401

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.